These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 219002)

  • 1. Nuclear receptors for 3,5,3'-triiodothyronine in human liver and kidney: characterization, quantitation, and similarities to rat receptors.
    Schuster LD; Schwartz HL; Oppenheimer JH
    J Clin Endocrinol Metab; 1979 Apr; 48(4):627-32. PubMed ID: 219002
    [No Abstract]   [Full Text] [Related]  

  • 2. Nuclear triiodothyronine receptor sites in brain: probable identity with hepatic receptors and regional distribution.
    Schwartz HL; Oppenheimer JH
    Endocrinology; 1978 Jul; 103(1):267-73. PubMed ID: 217638
    [No Abstract]   [Full Text] [Related]  

  • 3. Identical pattern of release of specific triiodothyronine receptors by micrococcal nuclease from rat cerebral cortex and liver nuclei.
    Silva JE
    Endocrinology; 1983 Aug; 113(2):699-705. PubMed ID: 6307648
    [No Abstract]   [Full Text] [Related]  

  • 4. Triiodothyronine nuclear receptor in chick embryo: nature and properties of hepatic receptor.
    Bellabarba D; Lehoux JG
    Endocrinology; 1981 Oct; 109(4):1017-25. PubMed ID: 6269827
    [No Abstract]   [Full Text] [Related]  

  • 5. Contributions of plasma triiodothyronine and local thyroxine monodeiodination to triiodothyronine to nuclear triiodothyronine receptor saturation in pituitary, liver, and kidney of hypothyroid rats. Further evidence relating saturation of pituitary nuclear triiodothyronine receptors and the acute inhibition of thyroid-stimulating hormone release.
    Silva JE; Larsen PR
    J Clin Invest; 1978 May; 61(5):1247-59. PubMed ID: 207733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear receptors and thyroid hormone action: a progress report.
    Oppenheimer JH; Dillmann WH; Schwartz HL; Towle HC
    Fed Proc; 1979 Jul; 38(8):2154-61. PubMed ID: 221272
    [No Abstract]   [Full Text] [Related]  

  • 7. Tissue differences in the concentration of triiodothyronine nuclear binding sites in the rat: liver, kidney, pituitary, heart, brain, spleen, and testis.
    Oppenheimer JH; Schwartz HL; Surks MI
    Endocrinology; 1974 Sep; 95(3):897-903. PubMed ID: 4369384
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of divalent cations on the binding of 3,5,3'-triiodothyronine to isolated rat liver nuclei.
    Rodriguez-Peña A; Bernal J
    Endocrinology; 1982 Jan; 110(1):246-53. PubMed ID: 6274620
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of nuclear 5,5,3'-triiodothyronine-binding capacity and tissue response in the liver of the neonatal rat.
    Coulombe P; Ruel J; Dussault JH
    Endocrinology; 1979 Oct; 105(4):952-9. PubMed ID: 225160
    [No Abstract]   [Full Text] [Related]  

  • 10. Common clinical indices of thyroid hormone action: relationships to serum free 3,5,3'-triiodothyronine concentration and estimated nuclear occupancy.
    Bantle JP; Dillmann WH; Oppenheimer JH; Bingham C; Runger GC
    J Clin Endocrinol Metab; 1980 Feb; 50(2):286-93. PubMed ID: 6243666
    [No Abstract]   [Full Text] [Related]  

  • 11. Humoral modulation of hepatic nuclear triiodothyronine receptors in the cross-circulated rat.
    Short J; McDermott P; Truitte D
    Horm Metab Res; 1982 Apr; 14(4):224. PubMed ID: 6282730
    [No Abstract]   [Full Text] [Related]  

  • 12. Limitations in the conventional analysis of the interaction of triiodothyronine with solubilized nuclear receptor sites. Inapparent binding of triiodothyronine to nonspecific binding sites.
    Seelig S; Schwartz HL; Oppenheimer JH
    J Biol Chem; 1981 Mar; 256(5):2154-61. PubMed ID: 6257704
    [No Abstract]   [Full Text] [Related]  

  • 13. Roentgenographic contrast agents inhibit triiodothyronine binding to nuclear receptors in vitro.
    DeGroot LJ; Rue PA
    J Clin Endocrinol Metab; 1979 Oct; 49(4):538-42. PubMed ID: 225345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triiodothyronine (T3) receptors in brain and liver during induced hypothyroidism in rats [proceedings].
    Dozin-Van Roye B; De Nayer P
    Arch Int Physiol Biochim; 1979 Feb; 87(1):172-3. PubMed ID: 92254
    [No Abstract]   [Full Text] [Related]  

  • 15. The contribution of local tissue thyroxine monodeiodination to the nuclear 3,5,3'-triiodothyronine in pituitary, liver, and kidney of euthyroid rats.
    Silva JE; Dick TE; Larsen PR
    Endocrinology; 1978 Oct; 103(4):1196-207. PubMed ID: 217671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nuclear receptors for triiodothyronine. I. Binding of triiodothyronine (T-3) in rat liver following in vivo administration of labelled hormone].
    Kubica A; Nauman A; Witkowska E; Nauman J
    Endokrynol Pol; 1977; 28(3):207-14. PubMed ID: 195802
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of nuclear receptor affinity for 3,5,3'-triiodothyronine by nucleotide in vitro.
    Brtko J; Knopp J
    Endocrinol Exp; 1985 Dec; 19(4):245-51. PubMed ID: 3002752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific nuclear triiodothyronine binding sites in rat liver and kidney.
    Oppenheimer JH; Koerner D; Schwartz HL; Surks MI
    J Clin Endocrinol Metab; 1972 Aug; 35(2):330-3. PubMed ID: 4561198
    [No Abstract]   [Full Text] [Related]  

  • 19. Preferential binding of 3,5-dimethyl-3'-isopropylthyroinine (DIMIT) to brain nuclear receptors for thyroid hormones.
    Dozin-van Roye B; Rennotte B; De Nayer P
    J Neurochem; 1980 Apr; 34(4):1030-1. PubMed ID: 6244361
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of decreased hepatic nuclear L-triiodothyronine receptors on the response of hepatic enzymes to L-triiodothyronine in tumor-bearing rats.
    Grajower MM; Surks MI
    Endocrinology; 1979 Mar; 104(3):697-703. PubMed ID: 220018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.